HIV treatment update – Winter 2013

Gus Cairns
Published: 21 February 2013

The new edition of HIV treatment update (HTU) is on its way to subscribers and is also available online at

What's in this issue?

There’s an unusually diverse mix of topics in this issue of HTU. You might say they span the ‘before, during and after’ of the HIV diagnosis experience.

Click on these links to get straight to the articles:

The piece on pre-exposure prophylaxis (PrEP wars) returns to a topic we’ve covered before, but which, as we show, is one of the most hotly debated ideas in HIV right now. Using medicines, including vaccines, to prevent rather than treat disease has always been a controversial issue, from MMR to water fluoridation, because the benefit/risk calculation feels trickier: how can you be sure you aren’t giving people what may harm them, to prevent what they might not get anyway?

Such feelings are often deeply held, not always rational and, in the case of HIV, can reach a particular sharpness. This is partly because advances in the tolerability of HIV medicines have happened so fast that many still see them as toxic drugs no one would take unless faced with death. But it’s also because people ask the obvious question: “Why don’t they use condoms?” – usually followed by a lament for the lack of efficacy of safer-sex campaigns. This isn’t the place to go into why people don’t, but the fact that many don’t means we need more alternatives, and PrEP is a possible – though not unproblematic – one.

Tales of the late diagnosed made me feel angry as I was researching it; so many near-deaths – and a tragic case of someone who died of AIDS, but could have been saved any time in the previous three years if only she’d been given an HIV test. No one is specifically to blame, though: as the piece makes clear, patient awareness, doctor awareness, testing availability and the fear of HIV all conspire to create a situation where far too many people still test far too late. A critical issue not only for their own health but, because they have spent all that time with detectable viral loads, for the health of partners too.

Finances for the over-50s had rather the opposite effect. There are certainly a lot of people around, like ‘Michael’ in the article, who face poverty in old age because they never assumed they would be old, and because they were out of the job market for years. The piece, however, reminds us that this is an issue shared with a lot of people who don’t have HIV (many HIV-negative people also leave it very late to prepare for their older age), and that there are possible remedies we may not have thought of.

One interesting aspect of the late-diagnosis and PrEP articles is that they don’t directly concern the health of HTU’s core readership – people with HIV. By definition, PrEP is for HIV-negative people, and we’ve already been diagnosed, late or otherwise. And yet people living with HIV are deeply involved in activism around both these questions.

This is partly because many of us are only too well acquainted with the harm that HIV can do, and we want to spare others the same experience. But it’s also because HIV activists tend not only to care passionately about their cause but are also an unusually scientifically literate bunch. We know what is likely to work and what’s likely to be a dud. Precisely because we are now living longer lives, it gives us the chance to give something back and to contribute as positive citizens.

For more information

To subscribe to HIV treatment update, to send us feedback on this edition, or for any other information, please contact us at or call 020 7837 6988. This edition is available in our archive, where you can read it online, view it as a flipbook and download it as a pdf. Visit

Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.